Life Sciences Introduction

GENOMICS

DECODING THE LANGUAGE OF GENES

At Kapia, our genomics division focuses on working with clients who are unraveling the mysteries hidden within our genes. Genomics, the study of an organism's complete set of DNA, has revolutionised our understanding of the language of genes. It encompasses a wide range of techniques and technologies aimed at deciphering the genetic code, unlocking valuable insights into the functioning and diversity of life. By unraveling the complexities encoded within DNA sequences, genomics provides a profound understanding of how genes determine traits, influence diseases, and shape evolutionary processes.

At the core of genomics lies DNA sequencing, the process of determining the order of nucleotides (A, T, C, and G) in a DNA molecule. Over the years, advancements in sequencing technologies have led to remarkable progress, enabling researchers to rapidly and cost- effectively sequence whole genomes. This breakthrough has paved the way for large-scale genomics projects, such as the Human Genome Project, which successfully sequenced the entire human genome and laid the foundation for personalised medicine and precision healthcare.

Decoding the language of genes involves more than just reading the DNA sequence. Genomic research also encompasses the analysis of gene expression, regulation, and functional elements. Scientists investigate how genes are activated or silenced in different issues and under various conditions, shedding light on the complex network of interactions that govern cellular processes. By identifying genetic variants and their associations with diseases, genomics helps uncover the underlying molecular mechanisms and aids in the development of targeted therapies.

Furthermore, genomics plays a crucial role in understanding the diversity of life on Earth. By comparing the genomes of different species, scientists can trace evolutionary relationships, identify genetic adaptations, and explore the origins of biological complexity. The field of comparative genomics provides valuable insights into the shared genetic heritage across organisms, highlighting both the similarities and unique characteristics that define different species.

In summary, genomics has transformed our ability to decode the language of genes, offering unprecedented opportunities to explore and comprehend the genetic basis of life. It has revolutionised medicine, agriculture, and ecology by enabling personalised healthcare, crop improvement, and conservation efforts. As genomics continues to advance, it holds immense potential for driving scientific discoveries, enhancing our understanding of biological systems, and improving human and environmental well-being.

Check out our latest life science Roles

PROTEOMICS

ILLUMINATING THE WORLD OF PROTEINS

In the realm of proteomics, Kapia’s work with clients who play a pivotal role in understanding the complex world of proteins. Proteomics, the study of proteins and their functions within biological systems, has emerged as a powerful field in modern scientific research. It involves the large-scale analysis of proteins, their structures, interactions, and modifications, with the ultimate goal of understanding their roles in various biological processes. By unraveling the complex web of proteins within cells, proteomics provides valuable insights into the molecular mechanisms that drive life.

One of the key areas of focus in proteomics is the identification and characterisation of proteins. Advancements in mass spectrometry, a technique that allows for the detection and quantification of proteins, have revolutionised this aspect of the field. Researchers can now analyse thousands of proteins simultaneously, providing a comprehensive view of cellular processes. This information helps in the discovery of potential biomarkers for diseases, understanding drug targets, and unraveling the intricacies of signaling pathways.

Another important aspect of proteomics is the study of protein-protein interactions. Proteins rarely act alone; they often form intricate networks of interactions within cells, enabling various cellular functions. By identifying and mapping these interactions, scientists can uncover how proteins collaborate to carry out biological processes. This knowledge is essential for understanding disease mechanisms and designing targeted therapies.

Furthermore, proteomics plays a crucial role in the study of post-translational modifications (PTMs). PTMs are chemical alterations that occur after protein synthesis and can profoundly impact protein function. Proteomic techniques allow researchers to identify and characterise PTMs, such as phosphorylation, acetylation, and methylation, providing insights into their regulatory roles and their involvement in disease processes.

Overall, proteomics serves as a powerful tool for understanding the intricate world of proteins. It enables researchers to elucidate protein functions, unravel complex cellular processes, and gain a deeper understanding of diseases. With ongoing advancements in technology and methodology, proteomics continues to illuminate the intricate network of proteins that underlie life, paving the way for new discoveries and applications in various fields, including medicine, biotechnology, and agriculture.

IN VITRO DIAGNOSTICS (IVD)

PIONEERING PRECISION MEDICINE

Kapia's IVD division is dedicated to working with clients and the forefront of development and validation of diagnostic tests. In Vitro Diagnostics (IVD) have emerged as a pioneering field within the realm of precision medicine. Precision medicine aims to tailor medical treatments and interventions to the unique characteristics of each individual patient. By integrating advanced technologies and techniques, IVD has revolutionised the way diseases are diagnosed, monitored, and treated, leading to more personalised and effective healthcare.

IVD encompasses a wide range of laboratory tests and diagnostic tools that are performed on patient samples outside the human body. These samples can include blood, urine, tissue, and other bodily fluids. Through the analysis of these samples, IVD enables healthcare professionals to obtain crucial information about a patient's health status, identify the presence of diseases, determine disease progression, and assess treatment response.

One of the key advantages of IVD in precision medicine is its ability to provide rapid and accurate diagnostic results. Advanced technologies, such as molecular diagnostics, next-generation sequencing, and immunohistochemistry, have significantly enhanced our understanding of diseases at a molecular level. This deeper understanding allows for the identification of specific biomarkers associated with certain diseases or genetic mutations, enabling early detection and targeted therapies.

Furthermore, IVD plays a vital role in guiding treatment decisions by providing clinicians with valuable information about a patient's genetic profile and disease characteristics. For instance, genetic tests can identify specific gene mutations that influence drug metabolism or treatment response, helping physicians choose the most suitable medications or therapies for an individual patient. This personalised approach minimises the risk of adverse reactions and maximizes treatment efficacy.

IVD has also contributed to the development of companion diagnostics, which are tests specifically designed to identify patients who are most likely to benefit from a particular therapy. These tests help ensure that medications are prescribed to patients who are likely to respond positively, avoiding unnecessary treatments and associated side effects. Companion diagnostics have been particularly valuable in the field of oncology, where targeted therapies have revolutionised cancer treatment.

In summary, IVD has become a cornerstone of precision medicine by revolutionising disease diagnosis, monitoring, and treatment. By harnessing advanced technologies and analysing biomarkers, IVD provides rapid and accurate results, enabling early detection, targeted therapies, and personalised medicine. As technology continues to advance, the field of IVD will undoubtedly play an increasingly crucial role in the delivery of precision medicine, improving patient outcomes and transforming healthcare as we know it.

CDMO

CONTRACT DEVELOPMENT AND MANUFACTURING ORGANISATION (CDMO): REALISING VISIONARY MEDICAL INNOVATIONS

Kapia’s CDMO division work with clients who are at the forefront of manufacturing a rage of pharmaceuticals. Contract Development and Manufacturing Organisation’s (CDMO) play a pivotal role in realising visionary medical innovations. In the dynamic landscape of the healthcare industry, where breakthroughs in pharmaceuticals and medical devices are constantly being pursued, CDMOs serve as strategic partners for companies seeking to bring their innovative ideas to fruition. These organisations specialise in providing comprehensive services throughout the entire product development and manufacturing lifecycle, enabling companies to streamline their processes and maximise their chances of success.

One of the primary advantages of partnering with a CDMO is the expertise and experience they bring to the table. These organizations are staffed with highly skilled professionals who possess deep knowledge of regulatory requirements, industry best practices, and emerging technologies. Their multidisciplinary teams, comprising scientists, engineers, technicians, and quality assurance personnel, work collaboratively to guide clients through the complex journey of product development. From initial concept design to formulation development, process optimization, and scale-up, CDMOs leverage their technical prowess and cutting- edge facilities to translate visionary ideas into tangible products.

Moreover, CDMOs offer a wide range of manufacturing capabilities to cater to diverse needs. Whether it's small-scale production for clinical trials or large-scale commercial manufacturing, these organisations possess the infrastructure and capabilities to meet the demands of their clients. State-of-the-art facilities equipped with advanced technologies and stringent quality control systems ensure that the products manufactured by CDMOs adhere to the highest standards of safety, efficacy, and quality. This enables companies to accelerate their time to market, reduce costs, and focus on their core competencies, while relying on the CDMO's expertise in manufacturing and supply chain management.

In addition to technical expertise and manufacturing capabilities, CDMOs also play a vital role in regulatory compliance. They possess a deep understanding of regulatory frameworks, such as Good Manufacturing Practices (GMP) and International Organisation for Standardisation (ISO) guidelines, and work closely with regulatory authorities to ensure that the products meet all necessary requirements. This regulatory expertise helps companies navigate the complex landscape of approvals, certifications, and audits, reducing the risk of delays and ensuring compliance with global standards.

In conclusion, Contract Development and Manufacturing Organisations (CDMOs) are instrumental in realising visionary medical innovations. Through their comprehensive services, technical expertise, manufacturing capabilities, and regulatory compliance support, CDMOs enable companies to transform their groundbreaking ideas into market-ready products. By partnering with CDMOs, companies can leverage their specialised knowledge and infrastructure, streamline their operations, and bring their transformative medical innovations to patients worldwide.

CRO

CONTRACT RESEARCH ORGANISATION (CRO): ACCELERATING DISCOVERIES, TRANSFORMING LIVES

Collaborating with pharmaceutical, biotechnology, and medical device companies, Kapia's CRO division collaborates with clients who accelerate the pace of research and development. A Contract Research Organisation (CRO) plays a key role in accelerating discoveries and transforming lives through its diverse range of services and expertise. CROs are instrumental in driving the success of pharmaceutical, biotechnology, and medical device companies by providing comprehensive support in the research and development (R&D) of new treatments and therapies. Their primary goal is to streamline the drug development process, from early-stage research to regulatory approval, ultimately leading to the availability of innovative and life-saving interventions.

One of the key ways in which CROs accelerate discoveries is by conducting clinical trials. These trials are essential for evaluating the safety and efficacy of new drugs or medical devices in human subjects. CROs employ experienced clinical research professionals who meticulously plan, execute, and monitor these trials, ensuring adherence to strict regulatory standards and guidelines. By efficiently managing and overseeing these trials, CROs enable the collection of reliable data, which in turn leads to informed decision-making and the advancement of medical knowledge.

Moreover, CROs contribute significantly to the acceleration of discoveries through their expertise in data management and analysis. They employ cutting-edge technologies and methodologies to process and interpret vast amounts of data generated during clinical trials. By employing sophisticated statistical techniques, CROs can extract meaningful insights from complex datasets, allowing researchers and pharmaceutical companies to make informed decisions about the potential efficacy and safety of a particular intervention. This expedites the identification of promising treatments and enhances the overall efficiency of the drug development process.

In addition to expediting the discovery of new treatments, CROs also play a crucial role in transforming lives. Through their dedication to patient safety and well-being, CROs ensure that clinical trials are conducted ethically and with the utmost regard for human subjects. By implementing stringent protocols and closely monitoring the welfare of participants, CROs contribute to the development of therapies that can improve the quality of life for patients suffering from various diseases and conditions. The work of CROs has led to the approval and availability of numerous life-saving medications and medical devices, making a significant impact on global healthcare.

In conclusion, Contract Research Organizations (CROs) are integral to accelerating discoveries and transforming lives in the field of healthcare. Through their expertise in clinical trials, data management, and patient safety, CROs streamline the drug development process, leading to the availability of innovative treatments and therapies. Their contributions not only expedite the discovery of new interventions but also have a profound impact on the lives of patients worldwide, offering hope and improved health outcomes.

ANALYTICAL INSTRUMENTATION

UNVEILING INSIGHTS THROUGH ADVANCED ANALYSIS

Kapia's Analytical Instrumentation division partner with organisations playing a crucial role in the field of scientific research, enabling scientists and engineers to unravel valuable insights through advanced analysis. This field encompasses a wide range of techniques and tools designed to measure, identify, and quantify various substances and properties in diverse sample matrices. By employing sophisticated instrumentation, scientists can delve deeper into the composition, structure, and behavior of substances, leading to breakthrough discoveries and informed decision-making in numerous industries.

One of the primary goals of analytical instrumentation is to provide accurate and precise measurements. Advanced analytical instruments employ cutting-edge technologies and methodologies to ensure high sensitivity, specificity, and reliability. These instruments can detect and quantify even trace amounts of target substances, aiding in the detection of contaminants, pollutants, and impurities. By obtaining precise measurements, scientists can evaluate the quality of materials, monitor environmental conditions, and assess the safety and efficacy of pharmaceuticals and other consumer products.

Furthermore, analytical instrumentation enables scientists to gain deeper insights into the molecular and atomic characteristics of substances. Techniques such as spectroscopy, chromatography, and mass spectrometry provide detailed information about the chemical composition, structural arrangement, and electronic properties of samples. This information can be crucial in fields like materials science, drug development, and environmental monitoring. By understanding the intricate details of substances, scientists can optimise manufacturing processes, design new materials with enhanced properties, and develop more effective therapies.

In addition to characterisation, analytical instrumentation also facilitates the study of dynamic processes. Real-time monitoring and analysis of samples enable researchers to observe reactions, transformations, and interactions as they occur. Techniques like electrochemical analysis, flow cytometry, and thermal analysis provide valuable data on the kinetics, rates, and mechanisms of chemical and biological processes. This knowledge is indispensable in fields such as catalysis, biochemistry, and drug discovery, as it allows scientists to optimize reaction conditions, study enzymatic activity, and evaluate drug efficacy.

In conclusion, analytical instrumentation plays a pivotal role in unlocking insights through advanced analysis. By employing state-of-the-art techniques and instruments, scientists can obtain precise measurements, unravel molecular details, and study dynamic processes. The continuous advancement of analytical instrumentation promises to drive further breakthroughs in various scientific disciplines, ultimately leading to improved technologies, better understanding of natural phenomena, and enhanced quality of life.

BIOINFORMATICS

HARNESSING THE POWER OF DATA

Bioinformatics is a rapidly evolving interdisciplinary field that combines biology, computer science, and statistics to extract valuable insights from biological data. Kapia partners with organisations who are pivotal to the advancement of high-throughput technologies, such as DNA sequencing and gene expression profiling, enormous amounts of biological data are being generated at an unprecedented rate. This data deluge has created the need for powerful computational tools and analytical techniques to make sense of the vast amount of information and extract meaningful knowledge.

Harnessing the power of data in bioinformatics has revolutionised various areas of biological research. It has played a pivotal role in genomics, enabling the sequencing of entire genomes and facilitating the study of genetic variations and their impact on health and disease. By analysing large-scale genomic data, researchers can identify disease-associated genetic mutations, predict drug responses, and develop personalised medicine approaches. Bioinformatics tools also aid in comparative genomics, allowing scientists to study the evolutionary relationships between different species and understand the underlying mechanisms of genetic diversity.

Moreover, bioinformatics has greatly contributed to the field of proteomics, which focuses on the study of proteins and their functions. With the help of computational algorithms, researchers can analyse mass spectrometry data to identify and quantify proteins, determine post-translational modifications, and explore protein-protein interactions. This information is crucial for unraveling the complex molecular mechanisms underlying biological processes and diseases, leading to the development of targeted therapies and biomarkers.

In addition to genomics and proteomics, bioinformatics has found applications in other areas of biological research, such as transcriptomics and metabolomics. Transcriptomics involves the study of gene expression patterns, while metabolomics focuses on the analysis of small molecules involved in cellular metabolism. By integrating and analysing large-scale transcriptomic and metabolomic datasets, bioinformatics enables researchers to gain insights into the dynamics of gene regulation, metabolic pathways, and the interactions between genes, proteins, and metabolites.

Overall, bioinformatics has become an indispensable tool in modern biology, allowing researchers to efficiently store, manage, analyse, and interpret vast amounts of biological data. It empowers scientists to uncover hidden patterns, discover novel biological insights, and accelerate the pace of scientific discoveries. By harnessing the power of data, bioinformatics holds the potential to revolutionise personalised medicine, drug discovery, and our understanding of complex biological systems.

DRUG DISCOVERY AND DEVELOPMENT

INNOVATING FOR BETTER HEALTHCARE

In the pursuit of discovering novel therapeutics, Kapia is actively involved in drug discovery and development. Drug discovery and development play a vital role in revolutionising healthcare and improving patient outcomes. The process of discovering and developing new drugs involves a multidisciplinary approach that combines scientific research, technological advancements, and regulatory considerations. By harnessing innovative strategies and cutting-edge technologies, researchers and pharmaceutical companies aim to address unmet medical needs, combat diseases, and enhance the overall quality of healthcare.

In recent years, there have been significant advancements in drug discovery and development, driven by scientific breakthroughs and technological innovations. One of the key areas of focus is the integration of genomics and personalised medicine. With the advent of next-generation sequencing and high-throughput screening techniques, scientists can analyse an individual's genetic profile and identify specific drug targets or biomarkers. This personalised approach allows for the development of targeted therapies that are tailored to an individual's genetic makeup, resulting in more effective treatments with reduced side effects.

Another area of innovation is the use of artificial intelligence (AI) and machine learning (ML) in drug discovery. These technologies enable researchers to analyse large datasets and identify patterns, accelerating the process of identifying potential drug candidates. AI and ML algorithms can also predict the properties of compounds, optimize drug design, and facilitate virtual screening, significantly reducing the time and cost involved in traditional drug discovery methods.

Furthermore, advancements in drug delivery systems have also revolutionised healthcare. Novel drug delivery methods, such as nanotechnology-based systems, allow for targeted drug delivery to specific tissues or cells, improving drug efficacy and minimising off-target effects. These systems can enhance the bioavailability of drugs, prolong their release, and improve patient compliance by offering alternative administration routes.

Innovations in drug discovery and development not only benefit the pharmaceutical industry but also have a profound impact on patients and healthcare providers. They enable the development of safer, more effective treatments, especially for previously untreatable or challenging diseases. By accelerating the drug development process and enhancing therapeutic outcomes, these innovations contribute to better healthcare and improved patient well-being.

However, it's important to note that drug discovery and development are complex and resource-intensive processes. Despite the advancements, challenges remain in terms of cost, regulatory hurdles, and the need for collaboration between academia, industry, and regulatory agencies. Addressing these challenges requires ongoing innovation, investment, and collaborative efforts to ensure that the potential of drug discovery and development continues to be realised, ultimately leading to better healthcare outcomes for individuals worldwide.

PHARMACOGENOMICS

PERSONALISING TREATMENT APPROACHES

Our pharmacogenomics division works with clients applying genetic information to optimise medication selection and dosing strategies. Pharmacogenomics is a rapidly advancing field in medicine that focuses on how an individual's genetic makeup influences their response to medications. It combines the disciplines of pharmacology and genomics to personalise treatment approaches based on a person's genetic profile. This innovative approach to medicine holds great promise for improving patient outcomes and minimising adverse drug reactions.

By analysing an individual's genetic variations, pharmacogenomics helps healthcare professionals determine the most effective and safe medications for each patient. These genetic variations can affect how a person's body metabolises drugs, how they respond to treatment, and their susceptibility to side effects. By understanding these genetic differences, healthcare providers can tailor drug therapies to optimise efficacy and reduce the risk of adverse events.

The implementation of pharmacogenomics has several practical applications in healthcare. For instance, it can aid in selecting the most suitable drug and dosage for a patient, increasing the chances of a positive therapeutic response. This personalised approach is particularly valuable in the treatment of conditions such as cancer, cardiovascular diseases, mental health disorders, and infectious diseases, where medication response can vary significantly among individuals.

Additionally, pharmacogenomics can help prevent adverse drug reactions, which are a major concern in healthcare. Adverse drug reactions are often unpredictable and can range from mild to severe, including life-threatening conditions. By identifying genetic markers associated with drug metabolism and response, healthcare providers can preemptively identify patients who are at a higher risk of adverse reactions. This knowledge enables healthcare professionals to adjust medication choices or dosages, thereby minimising the likelihood of negative outcomes.

In conclusion, pharmacogenomics offers a groundbreaking approach to personalised medicine by considering an individual's genetic information to optimize treatment approaches. By integrating genomics into clinical practice, healthcare professionals can make more informed decisions regarding drug selection, dosage, and treatment plans, leading to better patient outcomes and reduced healthcare costs. As research in this field continues to advance, pharmacogenomics holds the potential to revolutionise the way medications are prescribed, ensuring that each patient receives tailored treatment based on their unique genetic profile.

REGULATORY AFFAIRS

NAVIGATING COMPLIANCE AND APPROVALS

Kapia's regulatory affairs team works with experts looking to navigate the complex landscape of regulatory compliance and approvals in the life science industry. Regulatory affairs play a crucial role in navigating compliance and approvals in various industries, including pharmaceuticals, medical devices, food and beverages, cosmetics, and more. The field of regulatory affairs encompasses a range of activities and responsibilities aimed at ensuring that products meet the legal and regulatory requirements set by government authorities.

One of the primary objectives of regulatory affairs is to obtain and maintain regulatory approvals for products. This involves understanding the regulatory landscape and staying up-to-date with the evolving regulations and guidelines. Regulatory professionals work closely with regulatory agencies to prepare and submit applications for product approvals, such as new drug applications or medical device registrations. They are responsible for compiling all the necessary documentation, including scientific data, safety information, labeling details, and manufacturing processes, to demonstrate the quality, safety, and efficacy of the product.

Compliance is another key aspect of regulatory affairs. Regulatory professionals ensure that companies adhere to the applicable regulations and standards throughout the product lifecycle. They provide guidance and support to internal stakeholders, such as research and development teams, quality assurance departments, and manufacturing facilities, to ensure that products are developed, manufactured, and distributed in compliance with the regulatory requirements. This involves implementing robust quality management systems, conducting internal audits, and addressing any non-compliance issues promptly.

Furthermore, regulatory affairs professionals also play a vital role in monitoring and assessing the impact of regulatory changes on product development and commercialisation strategies. They provide regulatory intelligence and guidance to help companies adapt to new regulations, address potential risks, and make informed decisions. By staying abreast of regulatory developments, regulatory affairs professionals can help companies proactively manage compliance and ensure that their products remain in the market while meeting all regulatory obligations.

In summary, regulatory affairs professionals are essential for navigating compliance and approvals in various industries. Their expertise in understanding and interpreting regulations, obtaining and maintaining approvals, ensuring compliance, and monitoring regulatory changes enables companies to bring safe, effective, and compliant products to market. By working collaboratively with regulatory agencies, internal teams, and external stakeholders, regulatory affairs professionals contribute to the overall success and regulatory compliance of organisations.

CLINICAL TRIALS AND DATA MANAGEMENT

FACILITATING EVIDENCE-BASED MEDICINE

Kapia's clinical trials and data management division partner with organisations playing a pivotal role in conducting rigorous clinical studies and managing complex data sets. Clinical trials play a pivotal role in advancing evidence-based medicine by generating high-quality data to evaluate the safety and efficacy of medical interventions. These trials involve meticulous planning, implementation, and analysis of data, which requires efficient data management systems. Effective data management in clinical trials ensures the accuracy, integrity, and accessibility of the collected information, thereby enabling researchers and healthcare professionals to make well-informed decisions.

Data management in clinical trials begins with the design and development of robust protocols that outline the study objectives, inclusion criteria, outcome measures, and data collection methods. The data management team collaborates with investigators to establish comprehensive data capture systems, including electronic case report forms (eCRFs) and electronic data capture (EDC) systems. These tools streamline data collection, ensuring standardisation and minimising errors in data entry.

During the trial, data management personnel are responsible for monitoring data quality and completeness. They conduct regular checks to identify discrepancies, missing data, or outliers, working closely with investigators to resolve any issues promptly. Data cleaning processes, such as data validation, verification, and reconciliation, are implemented to ensure the accuracy and consistency of the collected data.

Furthermore, data management teams play a crucial role in ensuring data security and privacy. They adhere to strict regulations and guidelines, such as Good Clinical Data Management Practices (GCDMP), to protect patient confidentiality and comply with data protection regulations. Robust data encryption, access controls, and audit trails are employed to safeguard sensitive information.

As clinical trials generate vast amounts of data, efficient data analysis and reporting are vital. Data management professionals work closely with biostatisticians and researchers to perform statistical analyses, generate data summaries, and produce comprehensive study reports. Timely and accurate reporting facilitates the dissemination of trial results to regulatory authorities, scientific communities, and healthcare practitioners, supporting evidence-based decision-making and the advancement of medical knowledge.

In conclusion, effective data management is essential for facilitating evidence-based medicine through clinical trials. By establishing robust data capture systems, ensuring data quality and integrity, and safeguarding patient privacy, data management professionals contribute significantly to the generation of reliable and meaningful research outcomes. Their expertise in data analysis and reporting enables the translation of trial findings into clinical practice, ultimately improving patient care and advancing medical science.

Bridging Global Talent

Life Sciences Introduction

Our niche sub-industries:

Life Sciences Introduction

- Customer centric - Unapologetically bold
- Committed to relationships - Working as one

- Customer centric
- Unapologetically bold
- Committed to relationships
- Working as one

Find us

Ground Floor, Regus,
Princes Exchange,
Princes Square,
Leeds,
United Kingdom,
LS1 4HY

Follow us

LinkedIn

Instagram

Connect with us

info@kapia.io

0113 5263 330

Legal

Terms & Conditions

Website Cookie Policy

Acceptable Use Policy

Privacy Notice

Bridging Global Talent

Life Sciences Introduction

Our niche sub-industries:

Life Sciences Introduction

- Customer centric - Unapologetically bold - Committed to relationships - Working as one

- Customer centric - Unapologetically bold - Committed to relationships - Working as one

Find us

Ground Floor, Regus, Princes Exchange, Princes Square, Leeds, United Kingdom, LS1 4HY

Follow us

LinkedIn

Instagram

Connect with us

info@kapia.io

0113 5263 330

Legal

Terms & Conditions

Website Cookie Policy

Acceptable Use Policy

Privacy Notice

Branding & Marketing

We’ll help you challenge the conventions, provoke the assumptions and celebrate your uniqueness to win hearts, minds and new business. From conception to completion, we’ll give you all the brand design and ongoing brand management support you need to face your future with confidence.

- Customer centric - Unapologetically bold
- Committed to relationships - Working as one

- Customer centric
- Unapologetically bold
- Committed to relationships
- Working as one

Ground Floor, Regus,
Princes Exchange,
Princes Square,
Leeds,
United Kingdom,
LS1 4HY